Home / Escitalopram / Czechia
CZ ATC N06AB10 · updated 2 Nov 2026
Escitalopram shortage in Czechia
Is there an Escitalopram shortage in Czechia?
Yes. As of 2 Nov 2026, 7 Escitalopram products are reported short in Czechia, the first since 31 Dec 2025. The company estimate for the return is 1 Dec 2026 (latest 15 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Norway, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ESCITALOPRAM GRINDEKS 5MG 5MG TBL FLM 30 II | AS GRINDEKS, Riga | 31 Dec 2025 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ESCITALOPRAM VIATRIS 20MG 20MG TBL FLM 90 | VIATRIS LIMITED, Dublin | 21 Jun 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ITAKEM 10MG 10MG TBL FLM 28 | Teva | 11 Jul 2026 | not given | Manufacturing problem Výrobní důvody |
| CZ | ITAKEM 20MG 20MG TBL FLM 28 | Teva | 12 Aug 2026 | not given | Manufacturing problem Výrobní důvody |
| CZ | ELICEA 10MG 10MG TBL FLM 56 | Krka, d.d., Novo mesto, Novo mesto | 20 Oct 2026 | 1 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ESCITALOPRAM VIATRIS 10MG 10MG TBL FLM 90 anticipated | VIATRIS LIMITED, Dublin | 15 Nov 2026 | 31 Dec 2026 | Increased demand Zvýšené prodeje |
| CZ | ESCITALOPRAM MEDREG 10MG 10MG TBL FLM 30 anticipated | MEDREG s.r.o., Praha | 20 Dec 2026 | 15 Feb 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.